ANI Pharmaceuticals, Inc. (ANIP)
82.12
+0.09
(+0.11%)
USD |
NASDAQ |
Dec 11, 16:00
82.12
0.00 (0.00%)
After-Hours: 16:16
ANI Pharmaceuticals Cash from Investing (Quarterly): -6.163M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CorMedix, Inc. | -291.32M |
| Arcutis Biotherapeutics, Inc. | -25.25M |
| Intellia Therapeutics, Inc. | -0.741M |
| Beam Therapeutics, Inc. | 65.66M |
| Halozyme Therapeutics, Inc. | 201.61M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 44.06M |
| Cash from Financing (Quarterly) | 6.345M |
| Free Cash Flow | 136.04M |
| Free Cash Flow Per Share (Quarterly) | 1.796 |
| Free Cash Flow to Equity (Quarterly) | 52.72M |
| Free Cash Flow to Firm (Quarterly) | 41.61M |
| Free Cash Flow Yield | 8.19% |